Anti-ICOS antibodies
US9957323B2 · kind B2 · utility
14Cited by
27References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2017 |
| Grant date | May 1, 2018 |
| Priority date | — |
| Expiry date | Sep 7, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Methods of producing anti-ICOS antibodies, including species cross-reactive antibodies, using transgenic knock-out mice.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.